INVEX Therapeutics Ltd (IXC) — Net Asset Momentum
INVEX Therapeutics Ltd (IXC) recorded a net asset momentum of -25.5% as of June 2026, with net assets of AU$3.91 Million AUD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See IXC total equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
INVEX Therapeutics Ltd Net Asset Momentum (2019–2026)
This chart tracks INVEX Therapeutics Ltd's year-over-year net asset growth across 8 annual reporting periods from 2019 to 2026. The most recent momentum reading is -25.5%, with net assets of AU$3.91 Million AUD as of June 2026. For live market cap and overall valuation, see how much is INVEX Therapeutics Ltd worth.
Annual Net Asset History for INVEX Therapeutics Ltd (2019–2026)
The table below shows the complete annual net asset history for INVEX Therapeutics Ltd from 2019 to 2026, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check IXC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (AUD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | AU$3.91 Million | AU$4.06 Million | AU$153.47K | ▼ -25.5% |
| 2025 | AU$5.25 Million | AU$5.47 Million | AU$220.59K | ▼ -7.8% |
| 2024 | AU$5.69 Million | AU$6.12 Million | AU$431.63K | ▼ -73.2% |
| 2023 | AU$21.23 Million | AU$22.80 Million | AU$1.57 Million | ▼ -25.5% |
| 2022 | AU$28.48 Million | AU$29.49 Million | AU$1.00 Million | ▼ -11.2% |
| 2021 | AU$32.08 Million | AU$32.74 Million | AU$658.61K | ▲ +31.5% |
| 2020 | AU$24.40 Million | AU$26.42 Million | AU$2.02 Million | ▲ +113.3% |
| 2019 | AU$11.44 Million | AU$12.37 Million | AU$935.49K | — |